Additional Prognostic Value of Coronary Flow Reserve in Diabetic and Nondiabetic Patients With Negative Dipyridamole Stress Echocardiography by Wall Motion Criteria

Journal of the American College of Cardiology

Volumn 50, Issue 14, 2007, Pages 1354-1361

  Cortigiani, Lauro ^a   Rigo, Fausto ^b   Gherardi, Sonia ^c   Sicari, Rosa ^d   Galderisi, Maurizio ^e   Bovenzi, Francesco ^a   Picano, Eugenio ^d  

^a CAMPO DI MARTE HOSPITAL   (Italy)

^b Ospedale Umberto I   (Italy)

^c AUSL Cesena   (Italy)

^d INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^e FEDERICO II UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIABETIC PATIENT; DOPPLER ECHOCARDIOGRAPHY; DRUG MECHANISM; ECHOCARDIOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVASCULARIZATION; STRESS ECHOCARDIOGRAPHY;

CORONARY ARTERIOSCLEROSIS; DIABETES COMPLICATIONS; DIPYRIDAMOLE; ECHOCARDIOGRAPHY, STRESS; FEMALE; FOLLOW-UP STUDIES; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; VASODILATOR AGENTS;

EID: 34548841077     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.06.027     Document Type: Article

References (54)

1. Ryden L., Standl E., Bartnik M., et al., Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC)European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. Eur Heart J 28 (2007) 88-136
2. Berry C., Tardif J.-C., and Bourassa M.G. Coronary heart disease in patients with diabetes. Part I: recent advances in prevention and noninvasive management. J Am Coll Cardiol 49 (2007) 631-642
3. Bigi R., Desideri A., Cortigiani L., Bax J.J., Celegon L., and Fiorentini C. Stress echocardiography for risk stratification of diabetic patients with known or suspected coronary artery disease. Diabetes Care 24 (2001) 1596-1601
4. Elhendy A., Arruda A.M., Mahoney D.W., and Pellikka P.A. Prognostic stratification of diabetic patients by exercise echocardiography. J Am Coll Cardiol 37 (2001) 1551-1557
5. Marwick T.H., Case C., Sawada S., Vasey C., Short L., and Lauer M. Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. Diabetes Care 25 (2002) 1042-1048
6. Sozzi F.B., Elhendy A., Roelandt J.R., et al. Prognostic value of dobutamine stress echocardiography in patients with diabetes. Diabetes Care 26 (2003) 1074-1078
7. Cortigiani L., Bigi R., Sicari R., Landi P., Bovenzi F., and Picano E. Prognostic value of pharmacological stress echocardiography in diabetic and mondiabetic patients with known or suspected coronary artery disease. J Am Coll Cardiol 47 (2006) 605-610
8. Rigo F. Coronary flow reserve in stress-echo lab. From pathophysiologic toy to diagnostic tool. Cardiovasc Ultrasound 3 (2005) 8-19
9. Rigo F., Richieri M., Pasanisi E., et al. Usefulness of coronary flow reserve over regional wall motion when added to dual-imaging dipyridamole echocardiography. Am J Cardiol 91 (2003) 269-273
10. Nohtomi Y., Takeuchi M., Nagasawa K., et al. Simultaneous assessment of wall motion and coronary flow velocity in the left anterior descending coronary artery during dipyridamole stress echocardiography. J Am Soc Echocardiogr 16 (2003) 457-463
11. Lowenstein J., Tiano C., Marquez G., Presti C., and Quiroz C. Simultaneous analysis of wall motion and coronary flow reserve of the left anterior descending coronary artery by transthoracic Doppler echocardiography during dipyridamole stress echocardiography. J Am Soc Echocardiogr 16 (2003) 607-613
12. Chirillo F., Bruni A., De Leo A., et al. Usefulness of dipyridamole stress echocardiography for predicting graft patency after coronary artery bypass grafting. Am J Cardiol 93 (2004) 24-30
13. Ascione L., De Michele M., Accadia M., et al. Incremental diagnostic value of ultrasonographic assessment of coronary flow reserve with high-dose dipyridamole in patients with acute coronary syndrome. Int J Cardiol 106 (2006) 313-318
14. Rigo F., Gherardi S., Galderisi M., and Cortigiani L. Coronary flow reserve evaluation in stress-echocardiography lab. J Cardiovasc Med 7 (2006) 472-479
15. Rigo F., Cortigiani L., Pasanisi E., et al. The additional prognostic value of coronary flow reserve on left anterior descending artery in patients with negative stress echo by wall motion criteria. A transthoracic vasodilator stress echo study. Am Heart J 149 (2005) 684-689
16. L'Abbate A. Large and micro coronary vascular involvement in diabetes. Pharmacol Rep 57 Suppl (2005) 3-9
17. Galderisi M. Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography. J Am Coll Cardiol 48 (2006) 1548-1551
18. World Health Organization. World Health Organization: diabetes mellitus. Report of a WHO study group (Tech. Rep. Ser. no. 727) (1985), World Health Organization, Geneva
19. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report on the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 157 (1997) 2413-2446
20. Sacks F.M., Pfeffer M.A., Moye L.A., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335 (1996) 1001-1009
21. Dal Porto R., Faletra F., Picano E., Pirelli S., Moreo A., and Varga A. Safety, feasibility, and diagnostic accuracy of accelerated high-dose dipyridamole stress echocardiography. Am J Cardiol 87 (2001) 520-524
22. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
23. Armstrong W.F., Pellikka P.A., Ryan T., Crouse L., and Zoghbi W.A. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 11 (1998) 97-104
24. Picano E., Mathias Jr. W., Pingitore A., Bigi R., and Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo Dobutamine International Cooperative Study Group. Lancet 344 (1994) 1190-1192
25. Lauer M.S., Blackstone E.H., Young J.B., and Topol E.J. Cause of death in clinical research: time for a reassessment?. J Am Coll Cardiol 34 (1999) 618-620
26. Gibler W.B., Cannon C.P., Blomkalns A.L., et al. Practical implementation of the guidelines for unstable angina/non-ST-segment elevation myocardial infarction in the emergency department: a scientific statement from the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Society of Chest Pain Centers. Circulation 111 (2005) 2699-2710
27. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16 (1993) 434-444
28. Nathan D., Meigs J., and Singer D. The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is ... or is it?. Lancet 350 Suppl I (1997) 4-9
29. Haffner S.M., Letho S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229-234
30. Sicari R., Cortigiani L., Bigi R., Landi P., Raciti M., and Picano E. Prognostic value of pharmacological stress echocardiography is affected by concomitant antiischemic therapy at the time of testing. Circulation 109 (2004) 2428-2431
31. Yokoyama I., Momomura S., Ohtake T., et al. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 30 (1997) 1472-1477
32. Picano E., Palinkas A., and Amyot R. Diagnosis of myocardial ischemia in hypertensive patients. J Hypertens 19 (2001) 1177-1183
33. Lattanzi F., Picano E., Bolognese L., et al. Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans. Correlation with exercise electrocardiography. Circulation 83 (1991) 1256-1262
34. San Roman J.A., Vilacosta I., Castillo J.A., et al. Dipyridamole and dobutamine-atropine stress echocardiography in the diagnosis of coronary artery disease. Comparison with exercise stress test, analysis of agreement, and impact of antianginal treatment. Chest 110 (1996) 1248-1254
35. Ferrara N., Coltorti F., Leosco D., et al. Protective effect of beta-blockade on dipyridamole-induced myocardial ischaemia. Role of heart rate. Eur Heart J 16 (1995) 903-908
36. Longobardi G., Ferrara N., Leosco D., et al. Echo-dipyridamole stress test evaluation of isosorbide-5-mononitrate efficacy and tolerance in patients with coronary heart disease: interplay with sympathetic activity. J Cardiovasc Pharmacol 36 (2000) 50-55
37. Palinkas A., Toth E., Amyot R., Rigo F., Venneri L., and Picano E. The value of ECG and echocardiography during stress testing for identifying systemic endothelial dysfunction and epicardial artery stenosis. Eur Heart J 23 (2002) 1587-1595
38. Rigo F., Pratali L., Palinkas A., et al. Coronary flow reserve and brachial artery reactivity in patients with chest pain and "false positive" exercise-induced ST-segment depression. Am J Cardiol 89 (2002) 1141-1144
39. Di Carli M.F., Janisse J., Grunberger G., and Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 41 (2003) 1387-1393
40. Srinivasan M., Herrero P., McGill J.B., et al. The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus. J Am Coll Cardiol 46 (2005) 42-48
41. Schalkwijk C.G., and Stehouwer C.D. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci 109 (2005) 143-159
42. Schachinger V., Britten M.B., and Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101 (2000) 1899-1906
43. Suwaidi J.A., Hamasaki S., Higano S.T., Nishimura R.A., Holmes Jr. R.D., and Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101 (2000) 948-954
44. Albertal M., Voskuil M., Piek J.J., et al., Doppler Endpoints Balloon Angioplasty Trial Europe (DEBATE) II Study Group. Coronary flow velocity reserve after percutaneous interventions is predictive of periprocedural outcome. Circulation 105 (2002) 1573-1578
45. von Mering G.O., Arant C.B., Wessel T.R., et al., National Heart, Lung, and Blood Institute. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109 (2004) 722-725
46. Tsutsui J.M., Elhendy A., Anderson J.R., Xie F., McGrain A.C., and Porter T.R. Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography. Circulation 112 (2005) 1444-1450
47. Klaar U., Berger R., Gwechenberger M., et al. Relationship between dobutamine response of dyssynergic myocardium and angiographically documented blood supply. J Am Soc Echocardiogr 16 (2003) 949-957
48. Kaul S. There may be more to myocardial viability than meets the eye. Circulation 92 (1995) 2790-2799
49. Ross Jr. J. Assessment of ischemic regional myocardial dysfunction and its reversibility. Circulation 74 (1986) 1186-1190
50. Rigo F., Gherardi S., Galderisi M., et al. The prognostic impact of coronary flow reserve assessed by Doppler echocardiography in non-ischemic dilated cardiomyopathy. Eur Heart J 27 (2006) 1319-1323
51. Bolognese L., Neskovic A.N., Parodi G., et al. Left ventricular remodeling after primary coronary angioplasty. Patterns of left ventricular dilation and long-term prognostic implications. Circulation 106 (2002) 2351-2357
52. Rigo F., Varga Z., Di Pede F., et al. Early assessment of coronary flow reserve by transthoracic Doppler echocardiography predicts late remodeling in reperfused anterior myocardial infarction. J Am Soc Echocardiogr 17 (2004) 750-755
53. Picano E., Landi P., Bolognese L., et al. Prognostic value of dipyridamole echocardiography early after uncomplicated myocardial infarction: a large scale multicenter trial. Am J Med 11 (1993) 608-618
54. Uren N.G., Melin J.A., De Bruyne B., Wijns W., Baudhuin T., and Camici P.G. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 330 (1994) 1782-1788